Page last updated: 2024-08-24

rolofylline and Apoplexy

rolofylline has been researched along with Apoplexy in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Carson, PE; Cleland, JG; Cotter, G; Davison, BA; Delucca, P; Dittrich, H; Givertz, MM; Hauptman, PJ; Iragui, VJ; Lovett, DH; Mansoor, GA; Massie, BM; Metra, M; Miller, AB; Mohr, JP; O'Connor, CM; Piña, IL; Ponikowski, P; Salerno, CM; Teerlink, JR; Thomson, S; Varosy, PD; Voors, AA; Wolko, D; Zile, MR	1

Trials

1 trial(s) available for rolofylline and Apoplexy

Article	Year
The safety of an adenosine A(1)-receptor antagonist, rolofylline, in patients with acute heart failure and renal impairment: findings from PROTECT. Drug safety, 2012, Mar-01, Volume: 35, Issue:3 Topics: Acute Disease; Adenosine A1 Receptor Antagonists; Aged; Aged, 80 and over; Female; Follow-Up Studies; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Renal Insufficiency; Risk Factors; Stroke; Time Factors; Xanthines	2012

Article

Year

The safety of an adenosine A(1)-receptor antagonist, rolofylline, in patients with acute heart failure and renal impairment: findings from PROTECT.

Drug safety, 2012, Mar-01, Volume: 35, Issue:3

Topics: Acute Disease; Adenosine A1 Receptor Antagonists; Aged; Aged, 80 and over; Female; Follow-Up Studies; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Renal Insufficiency; Risk Factors; Stroke; Time Factors; Xanthines

2012